Detection times of drugs of abuse in blood, urine, and oral fluid

被引:348
作者
Verstraete, AG [1 ]
机构
[1] Ghent Univ Hosp, Clin Biol Lab, B-9000 Ghent, Belgium
关键词
detection time; matrix; drugs of abuse;
D O I
10.1097/00007691-200404000-00020
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Data on the detection times of drugs of abuse are based on studies of controlled administration to volunteers or on the analysis of biologic samples of subjects who are forced to stop their (often chronic) use of drugs of abuse, eg, because of imprisonment or detoxification. The detection times depend mainly on the dose and sensitivity of the method used and also on the preparation and route of administration, the duration of use (acute or chronic), the matrix that is analyzed, the molecule or metabolite that is looked for, the pH and concentration of the matrix (urine, oral fluid), and the interindividual variation in metabolic and renal clearance. In general, the detection time is longest in hair, followed by urine, sweat, oral fluid, and blood. In blood or plasma, most drugs of abuse can be detected at the low nanogram per milliliter level for I or 2 days. In urine the detection time of a single dose is 1.5 to 4 days. In chronic users, drugs of abuse can be detected in urine for approximately I week after last use, and in extreme cases even longer in cocaine and cannabis users. In oral fluid, drugs of abuse can be detected for 5-48 hours at a low nanogram per milliliter level. The duration of detection of GHB is much shorter. After a single dose of I or 2 ng of flunitrazepam, the most sensitive methods can detect 7-aminoflunitrazepam for up to 4 weeks in urine.
引用
收藏
页码:200 / 205
页数:6
相关论文
共 56 条
[1]   SCREENING FOR DRUGS OF ABUSE .1. OPIATES, AMPHETAMINES AND COCAINE [J].
BRAITHWAITE, RA ;
JARVIE, DR ;
MINTY, PSB ;
SIMPSON, D ;
WIDDOP, B .
ANNALS OF CLINICAL BIOCHEMISTRY, 1995, 32 :123-153
[2]   PROLONGED OCCURRENCE OF COCAINE IN HUMAN-SALIVA AND URINE AFTER CHRONIC USE [J].
CONE, EJ ;
WEDDINGTON, WW .
JOURNAL OF ANALYTICAL TOXICOLOGY, 1989, 13 (02) :65-68
[3]  
CONE EJ, 1990, J ANAL TOXICOL, V14, P1
[4]   Cocaine disposition in saliva following intravenous, intranasal, and smoked administration [J].
Cone, EJ ;
Oyler, J ;
Darwin, WD .
JOURNAL OF ANALYTICAL TOXICOLOGY, 1997, 21 (06) :465-475
[5]  
CONE EJ, 1989, J FORENSIC SCI, V34, P15
[6]   MARIJUANA-LACED BROWNIES - BEHAVIORAL-EFFECTS, PHYSIOLOGIC EFFECTS, AND URINALYSIS IN HUMANS FOLLOWING INGESTION [J].
CONE, EJ ;
JOHNSON, RE ;
PAUL, BD ;
MELL, LD ;
MITCHELL, J .
JOURNAL OF ANALYTICAL TOXICOLOGY, 1988, 12 (04) :169-175
[7]  
COOK CE, 1993, DRUG METAB DISPOS, V21, P717
[8]   Prevalence of drugs used in cases of alleged sexual assault [J].
ElSohly, MA ;
Salamone, SJ .
JOURNAL OF ANALYTICAL TOXICOLOGY, 1999, 23 (03) :141-146
[9]   Toxicological detection of the designer drug 3,4-methylenedioxyethylamphetamine (MDE, ''Eve'') and its metabolites in urine by gas chromatography mass spectrometry and fluorescence polarization immunoassay [J].
Ensslin, HK ;
Kovar, KA ;
Maurer, HH .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 1996, 683 (02) :189-197
[10]  
Foltz R, 1995, P CALIFORNIA ASS TOX, P20